M M B ™ ETHODS IN OLECULAR IOLOGY Series Editor John M. Walker School of Life Sciences University of Hertfordshire Hatfield, Hertfordshire, AL10 9AB, UK For other titles published in this series, go to www.springer.com/series/7651 Protocols for In Vitro Cultures and Secondary Metabolite Analysis of Aromatic and Medicinal Plants Edited by S. Mohan Jain and Praveen K. Saxena Department of Applied Biology, University of Helsinki, Helsinki, Finland Department of Plant Agriculture, University of Guelph, Guelph, ON, Canada Editor S. Mohan Jain Praveen K. Saxena Department of Applied Biology Department of Plant Agriculture University of Helsinki University of Guelph Helsinki Guelph, ON Finland Canada ISSN: 1064-3745 e-ISSN: 1940-6029 ISBN: 978-1-60327-286-5 e-ISBN: 978-1-60327-287-2 DOI: 10.1007/978-1-60327-287-2 Library of Congress Control Number: 2008942394 © Humana Press, a part of Springer Science+Business Media, LLC 2009 All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Humana Press, c/o Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013 USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or d issimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. While the advice and information in this book are believed to be true and accurate at the date of going to press, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein. Printed on acid-free paper springer.com Preface Plants consistently synthesize, accumulate, and use a bewildering range of secondary metabolites as a part of their overall defense strategy. Many of these metabolites have been used around the world as medicines for various human health problems. In fact, more than 80% of the world’s population relies on plants for principle health care. Nearly half of the medical prescriptions in the developed world are of plant origin. In recent years the quest for quality of life and a common belief that plants are “natu- ral and therefore safe” has paved the way for a wider acceptance of plant-based medi- cines worldwide. International trade in medicinal plants has become a major force in the global economy and the demand is increasing in both developed and developing countries. Thus, the continued rise in consumer demand for plant-based medicines and the expanding world population have resulted in indiscriminate harvest of wild species of medicinal plants. As well, a reduction of natural habitats for medicinal plants has placed many wild species in danger of extinction. The impact of rapid climate changes may also have an adverse effect on wild-plant species leading to the loss of useful genetic material. Most medicinal plants are harvested from the wild and the traditional agricultural and horticultural practices have not been developed even for most commonly used medicinal plant species. The quality and consistency of the products are the most challenging issues facing the plant-based medicines. The production of medicinal metabolites in plants is affected by plant genotype, growth environment cultivation, harvesting, processing, and distribution. Medicinal plant preparations may also be contaminated with microbes and soil contami- nants such as heavy metals, herbicides, pesticides, and other agricultural chemicals which can cause qualitative and quantitative changes in the levels of medicinal metabolites. The widespread occurrence of chemical variability and compromised quality of medici- nal plants remain the major factors in inconsistent results of clinical trials of plant-based medicines. New regulations are currently being developed internationally to ensure con- sistency, safety and efficacy of plant-based medicines as well as how they are developed, manufactured, and marketed. Clearly, there is an imminent need for the development of new technologies and production approaches to improve the overall strategy of medicinal plant production to comply with up-coming legal regulations. In vitro cell culture and controlled environment production systems offer an excellent opportunity for the selection and season-independent propagation of elite lines with specific, consistent levels of medicinal metabolites with minimum contamination. Additionally, the plant materials produced by in vitro techniques allow efficient application of the emerging analytical methods—such as metabonomics—for complete chemical profiling which has enormous potential for the discovery of new medicinal compounds. Traditional breeding programs for medicinal plants are generally difficult to establish primarily due to lack of defined chemistry of medicinal components. Little knowledge of the genetic regulation of pathways of potential bioactive molecules further compounds this problem. In vitro techniques such as somaclonal variation, chemical mutagenesis, haploidy, protoplast fusion, and genetic transformation are applicable to create novel v vi Preface germplasm. The impact of these techniques is perhaps greatest in the improvement of medicinal plants since the resulting genetic diversity may open avenues for the discovery of new medicinal metabolites and treatments. Furthermore, the genetic manipulation of plant cells and organs has great advantages for producing secondary metabolites and other bioactive natural products. Together with the tools of chemical and genomic analyses, the in vitro culture methods hold the key to fundamental research on the biochemical and molecular basis of the mode of action of plant-based medicines. This book provides a detailed step-by-step description of protocols for the establishment of in vitro cultures of important medicinal plants, their mass multiplication in a controlled environment, and step-wise secondary metabolite analysis, genetic transformation, large-scale metabolite production in a bioreactor, and molecular markers. The role of altered microgravity in plant metabolite production is also described. In addition, many of these protocols will provide a basis for much needed efforts of in vitro germplasm conservation or cryopreser- vation of medicinal plant species at the brink of extinction as well as efforts to protect them from the adverse impact of rapid climatic changes. This book will certainly appeal to graduate and post graduate students, researchers, biotechnologists, industry, government agencies, and could be used as a text book. This book contains 31 book chapters, divided into five sections. Section I contains 16 chapters describing step-wise protocols for micropropagation and chemical analysis of secondary compounds of different medicinal plants. Section II contains five chapters which address the transgenic approach for producing secondary metabolites. Section III contains two chapters which cover molecular markers/microsatellites. Section IV has six chapters which address biotransformation, bioreactors, and metablomics. Finally, section V contains two review chapters describing plant secondary metabolites in altered micro- gravity and role of biotechnology in producing anti-cancer compounds. Each chapter has been peer reviewed and revised accordingly. We appreciate the time and effort that all reviewers have put into the development of these chapters which aided in improving the quality of the material presented herein. We extend our most sincere thanks to the staff of Humana Press for giving us the opportunity to present this book to our audience. Helsinki, Finland S. Mohan Jain Guelph, Canada Praveen K. Saxena Contents Preface ........................................................................................................................... v Contributors .................................................................................................................. xi PART I: MICROPROPAGATION AND CHEMICAL ANALYSIS 1. Establishment of Adventitious Root Cultures of Echinacea purpurea for the Production of Caffeic Acid Derivatives ........................................ 3 Kee-Yoeup Paek, Hosakatte Niranjana Murthy, and Eun-Joo Hahn 2. In Vitro Propagation of Rauwolfia serpentina Using Liquid Medium, Assessment of Genetic Fidelity of Micropropagated Plants, and Simultaneous Quantitation of Reserpine, Ajmaline, and Ajmalicine ................. 17 M.K. Goel, S. Mehrotra, A.K. Kukreja, K. Shanker, and S.P.S. Khanuja 3. Medicinal Properties, In Vitro Protocols and Secondary Metabolite Analyses of Scots Pine .................................................. 35 Hely Häggman, Anna Maria Pirttilä, Karoliina Niemi, Tytti Sarjala, and Riitta Julkunen-Tiitto 4. Saussurea medusa Cell Suspension Cultures for Flavonoid Production ...................................................................................... 53 Chun-Zhao Liu and Praveen K. Saxena 5. Large-scale In Vitro Multiplication of Crataeva nurvala ....................................... 61 Shashi B. Babbar, Neetika Walia, and Amandeep Kaur 6. Bilberry In Vitro Protocols and Analyses of Phenolic Compounds ....................................................................................... 71 Laura Jaakola, Kaisu Riihinen, Hely Häggman, and Anja Hohtola 7. In Vitro Propagation of Two Tuberous Medicinal Plants: Holostemma ada-kodien and Ipomoea mauritiana .................................................. 81 S. Pillai Geetha, A.V. Raghu, Gerald Martin, Satheesh George, and Indira Balachandran 8. In Vitro Production of Gymnemic Acid from Gymnema sylvestre (Retz) R. Br. Ex Roemer and Schultes Through Callus Culture Under Abiotic Stress Conditions .................................................... 93 Abdul Bakrudeen Ali Ahmed, Adhikarla Suryanarayana Rao, and Mandali Venkateswara Rao 9. Establishment of Plant Regeneration and Cryopreservation System from Zygotic Embryo-Derived Embryogenic Cell Suspension Cultures of Ranunculus kazusensis ...................................................... 107 Suk Weon Kim and Myung Jin Oh 10. In Vitro Culture and Secondary Metabolite Isolation in Bryophytes ...................... 117 Aneta Sabovljevic, Marko Sabovljevic, and Nebojsa Jockovic vii viii Contents 11. Micropropagation and In Vitro Conservation of Vanilla (Vanilla planifolia Andrews) ................................................................................. 129 Minoo Divakaran and K. Nirmal Babu 12. Protocol for In Vitro Regeneration and Marker Glycoside Assessment in Swertia chirata Buch-Ham ............................................................. 139 Sushma Koul, K. A. Suri, P. Dutt, M. Sambyal, A. Ahuja, and M.K. Kaul 13. Protocols for Establishment of an In Vitro Collection of Medicinal Plants in the Genus Scutellaria ......................................................... 155 Ian B. Cole, Faisal T. Farooq, and Susan J. Murch 14. Protocols for In Vitro Culture and Phytochemical Analysis of Phyllanthus Species (Euphorbiaceae) ................................................................. 167 Elizabete Catapan, Fábio Netto Moreno, Márcio Luís Busi da Silva, Michel Fleith Otuki, Rivaldo Niero, Valdir Cechinel Filho, Rosendo Augusto Yunes, and Ana Maria Viana 15. In Vitro Clonal Propagation of Asparagus racemosus, a High Value Medicinal Plant ................................................................................ 179 Sanjay Saxena and Nishritha Bopana 16. Micropropagation of Penthorum chinense Through Axillary Buds ........................................................................................................ 191 Jun Yang and Zheng-song Peng PART II: TRANSGENIC APPROACHES 17. Spontaneous Plant Regeneration and Production of Secondary Metabolites from Hairy Root Cultures of Centaurium erythraea Rafn .............................................................................. 205 Angelina Subotic´ , Slad¯ana Jevremovic´, Dragoljub Grubišic´ , and Teodora Jankovic´ 18. Transgenic Hypericum perforatum ........................................................................ 217 G. Franklin, Margarida M. Oliveira, and Alberto C.P. Dias 19. Agrobacterium-Mediated Transformation of Ruta graveolens L. ............................................................................................ 235 Karine Lièvre, Thi Lê Minh Tran, Sébastien Doerper, Alain Hehn, Paul Lacoste, Brigitte Thomasset, Frédéric Bourgaud, and Eric Gontier 20. Gene Expression Profiling in Taxus baccata L. Seedlings and Cell Cultures ........... 249 Katarína Brunˇáková and Ján Košuth 21. Catapol Production in Chinese Foxglove (Rehmannia glutinosa Libos.) Hairy Roots Transformed with Agrobacterium rhizogenes ATCC15834 ......................................................... 263 Sung Jin Hwang PART III: MOLECULAR MARKERS AND MICROSATELLITES 22. Identification of Medicinal Plants and Plant Sequences: A Multiplexed MLPA Assay .................................................................................. 277 Roger A. Barthelson Contents ix 23. Isolation of Microsatellites from Catharanthus roseus (L.) G. Don Using Enriched Libraries. ......................................................................... 289 Sabhyata Bhatia and Bhumika Shokeen PART IV: BIOTRANSFORMATION, BIOREACTORS, AND METABOLOMICS 24. Production of Cinnamyl Glycosides in Compact Callus Aggregate Cultures of Rhodiola rosea Through Biotransformation of Cinnamyl Alcohol ................................................................ 305 Zsuzsanna György and Anja Hohtola 25. Spearmint Plantlet Culture System as a Means to Study Secondary Metabolism ............................................................................ 313 Brent Tisserat, Mark Berhow, and Steven F. Vaughn 26. Bioreactor Production of Secondary Metabolites from Cell Cultures of Periwinkle and Sandalwood ................................................. 325 Jagan V. Valluri 27. Camptothecin Production by In Vitro Cultures and Plant Regeneration in Ophiorrhiza Species .......................................................................................... 337 Takashi Asano, Hiroshi Sudo, Mami Yamazaki, and Kazuki Saito 28. Metabolomic Analysis of Ocotea odorifera Cell Cultures: A Model Protocol for Acquiring Metabolite Data.................................................. 347 Marcelo Maraschin, Paulo Fernando Dias, Ênio Luiz Pedrotti, Hiliana Nunes Ferreira Morais, Ana Maria Viana, and Karl Vernon Wood 29. The Production of 9-methoxycanthin-6-one from Callus Cultures of (Eurycoma longifolia Jack) Tongkat Ali ............................................... 359 Mahmood Maziah and Noormi Rosli PART V: ALTERED GRAVITY AND BIOTECHNOLOGY 30. Plant Secondary Metabolism in Altered Gravity ..................................................... 373 Lindsey K. Tuominen, Lanfang H. Levine, and Mary E. Musgrave 31. The Role of Biotechnology in the Production of the Anticancer Compound Podophyllotoxin ..................................................... 387 Hemant Lata, Cassia S. Mizuno, and Rita M. Moraes Index ........................................................................................................................... 403 Contributors ABDUL BAKRUDEEN ALI AHMED (cid:129) Department of Plant Science, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India A. AHUJA (cid:129) Biodiversity and Applied Botany Division, Indian Institute of Integrative Medicine, Jammu, India TAKASHI ASANO (cid:129) Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan, CREST, Japan Science and Technology Agency, Saitama, Japan SHASHI B. BABBAR (cid:129) Department of Botany, University of Delhi, Delhi, India K. NIRMAL BABU (cid:129) Indian Institute of Spices Research, Kerala, India INDIRA BALACHANDRAN (cid:129) Centre for Medicinal Plants Research, Arya Vaidya Sala, Kerala, India ROGER A. BARTHELSON (cid:129) Plant Sciences, University of Arizona, Tucson, AZ MARK BERHOW (cid:129) New Crops and Processing Technology Research, National Center for Agricultural Utilization Research, Agricultural Research Service-USDA, Peoria, IL SABHYATA BHATIA (cid:129) National Institute of Plant Genome Research, Aruna Asaf Ali Marg, New Delhi, India NISHRITHA BOPANA (cid:129) TERI University, New Delhi, India FRÉDÉRIC BOURGAUD (cid:129) UMR Nancy-Université-INRA Agronomie et Environnement Nancy-Colmar, Vandoeuvre-Lès-Nancy, France KATARÍNA BRU N˘ÁKOVÁ (cid:129) P. J. Šafárik University in Košice, Faculty of Science, Institute of Biology and Ecology, Košice, Slovakia ELIZABETE CATAPAN (cid:129) Departamento de Botânica, Universidade Federal de Santa Catarina, Florianopolis, SC, Brazil IAN B. COLE (cid:129) Chemistry, I.K. Barber School of Arts & Sciences, University of British Columbia, Okanagan, Kelowna, BC, Canada MÁRCIO LUÍS BUSI DA SILVA (cid:129) Departamento de Botânica, Universidade Federal de Santa Catarina, Florianopolis, SC, Brazil ALBERTO C.P. DIAS (cid:129) Departamento de Biologia, Universidade do Minho, Campus de Gualtar, Braga, Portugal PAULO FERNANDO DIAS (cid:129) Plant Morphogenesis and Biochemistry Laboratory, Federal University of Santa Catarina, Florianopolis, SC, Brazil MINOO DIVAKARAN (cid:129) Providence Women’s College, Kerala, India SÉBASTIEN DOERPER (cid:129) UMR Nancy-Université-INRA Agronomie et Environnement Nancy-Colmar, Vandoeuvre-Lès-Nancy, France P. DUTT (cid:129) Natural Product Chemistry Division, Indian Institute of Integrative Medicine, Jammu, India FAISAL T. FAROOQ (cid:129) Chemistry, I.K. Barber School of Arts & Sciences, University of British Columbia, Okanagan, Kelowna, BC, Canada VALDIR CECHINEL FILHO (cid:129) Núcleo de Investigações Químico-Farmacêuticas, Universidade do Vale do Itajaí, Itajaí, SC, Brazil G. FRANKLIN (cid:129) Departamento de Biologia, Universidade do Minho, Campus de Gualtar, Braga, Portugal xi
Description: